Thursday February 20, 2020

Broadlake sells skincare brand to US company for €25m

Investment firm makes over three times return on capital

7th January, 2018
Alyson Hogg, founder and chief executive of Vita Liberata Picture: Tony O’Shea

Private investment company Broadlake achieved a three-times-plus return on its capital from the estimated $30 million (€25 million) sale last week of Vita Liberata, the Northern Ireland-headquartered skincare and self-tan brand, to US-based Crown Laboratories.

Broadlake, which is led by Pete Smyth, has exited businesses worth over €100 million since November after the recent sale of shower enclosures maker Merlyn Industries for over €68 million. The Dublin-based fund made a four-times return on its investment in...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Related Stories

What’s coming up today and what you might have missed

Hannah O’Brien | 2 months ago

What’s coming up today and what you might have missed.

Hannah O’Brien | 2 months ago